Monitoring and Management of Patients on Pressure-Controlled Ventilation in the Intensive Care Unit: A Comprehensive Review
Dr Neera Manikath, claude.Ai
Abstract
Pressure-controlled ventilation (PCV) remains a cornerstone ventilation strategy in the intensive care unit (ICU), particularly for patients with acute respiratory distress syndrome (ARDS), severe hypoxemia, or those requiring protective lung ventilation. This review provides a comprehensive and evidence-based approach to monitoring and managing patients on invasive PCV in the ICU setting. We explore the physiological principles, indications, monitoring parameters, troubleshooting strategies, and latest evidence-based approaches to optimize patient outcomes. Particular emphasis is placed on a systematic approach to ventilator adjustments, prevention of ventilator-induced lung injury, and weaning strategies. This review aims to serve as a practical guide for ICU clinicians managing patients on PCV.
Introduction
Mechanical ventilation represents one of the most common life-sustaining interventions in the ICU, with pressure-controlled ventilation (PCV) being a frequently employed mode. Unlike volume-controlled ventilation, PCV delivers breaths with a preset inspiratory pressure, resulting in variable tidal volumes based on lung compliance and airway resistance. This approach offers potential advantages for certain patient populations, including those with ARDS, severe hypoxemia, and those at risk for barotrauma.
The management of patients on PCV requires meticulous monitoring, systematic assessment, and evidence-based interventions to optimize outcomes while minimizing complications. Despite technological advances in ventilator capabilities, the fundamental principles of patient assessment, monitoring, and ventilator adjustment remain paramount to successful management.
This review synthesizes current evidence and clinical expertise to provide a comprehensive guide for postgraduate clinicians managing patients on invasive PCV in the ICU. We outline a step-by-step approach to monitoring parameters, interpreting ventilator graphics, troubleshooting common issues, and implementing evidence-based strategies for ventilator adjustment and weaning.
Physiological Principles of Pressure-Controlled Ventilation
Basic Mechanics and Terminology
Pressure-controlled ventilation is characterized by a constant inspiratory pressure delivered for a set inspiratory time, followed by passive exhalation. Key parameters in PCV include:
- Peak inspiratory pressure (PIP): The maximum pressure applied during inspiration, set by the clinician
- Positive end-expiratory pressure (PEEP): The pressure maintained at the end of exhalation
- Driving pressure (ΔP): The difference between PIP and PEEP
- Inspiratory time (Ti): The duration of the inspiratory phase
- Inspiratory-to-expiratory ratio (I:E ratio): The ratio of inspiratory time to expiratory time
- Respiratory rate (RR): The number of breaths delivered per minute
Understanding the relationship between these parameters is essential for effective ventilator management. Unlike volume-controlled ventilation, where tidal volume is constant and pressure varies with lung mechanics, PCV delivers a constant pressure resulting in variable tidal volumes based on the patient's lung compliance and airway resistance.
Physiological Effects
PCV affects multiple physiological parameters:
1. Gas distribution: The decelerating flow pattern in PCV may promote more homogeneous gas distribution in heterogeneous lung disease.
2. Mean airway pressure: PCV typically maintains higher mean airway pressures compared to volume-controlled ventilation, potentially improving oxygenation.
3. Work of breathing: In assisted modes, PCV can reduce work of breathing by providing a rapid rise to the set inspiratory pressure.
4. Cardiovascular interaction: The pressure-limited nature of PCV may reduce negative hemodynamic effects compared to volume-controlled ventilation, particularly in patients with compromised cardiovascular function.
Indications and Patient Selection for PCV
Pressure-controlled ventilation is particularly beneficial in:
1. Acute respiratory distress syndrome (ARDS): PCV may facilitate lung-protective ventilation strategies by controlling peak pressures and minimizing pressure-related lung injury.
2. Status asthmaticus: The pressure-limited approach may reduce the risk of barotrauma in patients with severe airflow obstruction.
3. Patients with bronchopleural fistulas: PCV may help manage air leaks more effectively than volume-controlled modes.
4. Post-operative cardiothoracic surgery patients: May benefit from the improved gas distribution patterns associated with PCV.
5. Patients with reduced lung compliance: PCV ensures pressure limitation while allowing tidal volume to vary based on changing lung mechanics.
Systematic Approach to Monitoring Patients on PCV
### Initial Assessment
A thorough initial assessment should include:
1. Patient history and clinical examination: Including underlying condition necessitating ventilation, duration of mechanical ventilation, previous ventilation strategies, and presence of complications.
2. Cardiopulmonary examination: Assessment of breath sounds, chest wall movement, work of breathing, and cardiovascular stability.
3. Current ventilator settings: Document all parameters including mode, PIP, PEEP, FiO₂, respiratory rate, inspiratory time, and I:E ratio.
4. Patient-ventilator synchrony: Assess for signs of dyssynchrony including use of accessory muscles, paradoxical breathing, and ventilator alarms.
Continuous Monitoring Parameters
Respiratory Parameters
1. Tidal volume (Vt):
- Target 6-8 mL/kg predicted body weight for most patients
- Lower tidal volumes (4-6 mL/kg) may be appropriate in ARDS
- Monitor for significant changes as an indicator of changing lung compliance or airway resistance
2. Minute ventilation (MV):
- Normal range: 5-10 L/min
- Evaluate in context of PaCO₂ and metabolic requirements
- Excessive MV may indicate respiratory distress or metabolic acidosis
3. Respiratory mechanics:
- Static compliance (Cstat): Normal range 60-100 mL/cmH₂O
- Dynamic compliance (Cdyn): Typically lower than static compliance
- Airway resistance (Raw): Normal <10 cmH₂O/L/sec
- Auto-PEEP: Ideally <5 cmH₂O
4. Plateau pressure monitoring:
- Requires inspiratory hold maneuver
- Target <30 cmH₂O to minimize ventilator-induced lung injury
- Calculate driving pressure (plateau pressure minus PEEP)
5. Work of breathing:
- Pressure-time product
- Signs of increased work: accessory muscle use, paradoxical breathing, tachypnea
Gas Exchange Parameters
1. Oxygenation:
- SpO₂: Target 92-96% (88-92% in COPD patients)
- PaO₂: Target >60 mmHg
- P/F ratio (PaO₂/FiO₂): Normal >300 mmHg
- Mild ARDS: 200-300 mmHg
- Moderate ARDS: 100-200 mmHg
- Severe ARDS: <100 mmHg
- Oxygenation index (OI): (FiO₂ × Mean airway pressure × 100)/PaO₂
2. Ventilation:
- PaCO₂: Target 35-45 mmHg (higher values may be acceptable in specific conditions)
- End-tidal CO₂ (ETCO₂): Typically 2-5 mmHg less than PaCO₂
- Dead space fraction (Vd/Vt): Normal <0.3; elevated in pulmonary embolism, ARDS
Cardiovascular Parameters
1. Hemodynamic monitoring:
- Blood pressure: Mean arterial pressure >65 mmHg
- Heart rate and rhythm
- Central venous pressure (if available): 8-12 mmHg
- Cardiac output/index (if available)
2. Fluid balance:
- Daily weights
- Input/output records
- Cumulative fluid balance
Ventilator Graphics Interpretation
1. Pressure-time curves:
- Ensure appropriate rise time to reach target inspiratory pressure
- Evaluate for pressure overshoots or undershoots
- Assess for auto-PEEP (failure to return to set PEEP before next breath)
2. Flow-time curves:
- Characteristic decelerating flow pattern
- Evaluate for flow reversal during inspiration (suggesting air trapping)
- Assess for incomplete exhalation (flow not returning to zero before next breath)
3. Volume-time curves:
- Identify delivered tidal volume
- Evaluate for stability of breath-to-breath volumes
4. Pressure-volume loops:
- Assess for hysteresis
- Identify lower and upper inflection points
- Evaluate for overdistension (flattening of upper portion)
Laboratory Monitoring
1. Arterial blood gases (ABGs):
- Schedule: Initially every 30 minutes after ventilator changes until stable, then every 4-6 hours or as clinically indicated
- Parameters: pH, PaO₂, PaCO₂, HCO₃⁻, base excess, lactate
2. Serum electrolytes:
- Daily monitoring of sodium, potassium, calcium, magnesium, phosphate
- More frequent monitoring if receiving continuous renal replacement therapy
3. Complete blood count:
- Daily monitoring of hemoglobin, white blood cell count, platelet count
4. Inflammatory markers:
- C-reactive protein, procalcitonin as needed
- Daily monitoring in sepsis
5. Renal and liver function:
- Daily monitoring of creatinine, blood urea nitrogen, liver enzymes
Additional Monitoring Considerations
1. Sedation and analgesia assessment:
- Richmond Agitation-Sedation Scale (RASS) or Sedation-Agitation Scale (SAS)
- Pain scales appropriate for ventilated patients
- Daily sedation interruption when appropriate
2. Nutrition status:
- Daily caloric intake
- Protein delivery
- Gastric residual volumes if enteral feeding
3. Chest imaging:
- Daily chest radiographs initially, then as clinically indicated
- Consider lung ultrasound for real-time assessment
4. Ventilator-associated pneumonia surveillance:
- Clinical Pulmonary Infection Score (CPIS)
- Daily assessment for purulent secretions, new infiltrates, fever
Step-by-Step Approach to Ventilator Adjustments in PCV
Initial Ventilator Setup
1. Mode selection:
- PCV (pressure-controlled ventilation)
- PC-CMV (pressure-controlled continuous mandatory ventilation)
- PC-AC (pressure-controlled assist-control)
- Note: Terminology varies between ventilator manufacturers
2. Initial settings:
- Peak inspiratory pressure (PIP): Start at 15-20 cmH₂O above PEEP
- PEEP: Initially 5-8 cmH₂O; adjust based on oxygenation requirements and underlying condition
- FiO₂: Initially 100%, then titrate down to maintain SpO₂ >92% (or target range)
- Respiratory rate: 14-18 breaths/min (adjust based on PaCO₂)
- Inspiratory time: 0.8-1.2 seconds (adjust to achieve I:E ratio of 1:2 to 1:3)
3. Initial assessment after setup:
- Verify delivered tidal volume (aim for 6-8 mL/kg predicted body weight)
- Assess oxygenation (SpO₂, PaO₂)
- Assess ventilation (ETCO₂, PaCO₂)
- Check patient-ventilator synchrony
- Assess hemodynamic response
Optimizing Oxygenation
1. PEEP optimization:
- Incremental PEEP titration: Increase PEEP by 2 cmH₂O every 15-30 minutes while monitoring oxygenation
- Decremental PEEP titration: After recruitment maneuver, decrease PEEP incrementally until deterioration in oxygenation, then increase by 2 cmH₂O
- PEEP/FiO₂ tables: Use standardized tables as in ARDSnet protocols
- Stress index assessment: Analyze pressure-time curve during constant flow
- Electrical impedance tomography (if available): Optimize PEEP based on regional ventilation
2. FiO₂ adjustment:
- Initial setting: 100%
- Titrate down in increments of 5-10% to maintain target SpO₂ (92-96%)
- Aim for FiO₂ ≤60% when possible to minimize oxygen toxicity
- Consider FiO₂ weaning before PEEP reduction
3. Recruitment maneuvers (when indicated):
- Sustained inflation: 30-40 cmH₂O for 30-40 seconds
- Staircase recruitment: Incremental increases in PEEP and driving pressure
- Monitor hemodynamic response closely during recruitment
4. I:E ratio manipulation:
- Consider inverse ratio ventilation (I:E >1:1) for refractory hypoxemia
- Requires close monitoring for auto-PEEP and hemodynamic compromise
- May require deeper sedation or neuromuscular blockade
Optimizing Ventilation (CO₂ Elimination)
1. Respiratory rate adjustment:
- Increase rate to enhance CO₂ elimination
- Consider impact on auto-PEEP, especially with short expiratory times
- Target pH >7.25 (permissive hypercapnia may be appropriate in certain conditions)
2. Inspiratory pressure adjustment:
- Increase driving pressure to enhance tidal volume and CO₂ elimination
- Monitor for plateau pressures >30 cmH₂O
- Calculate and monitor driving pressure (plateau pressure - PEEP), targeting <15 cmH₂O
3. Dead space management:
- Optimize circuit setup to minimize mechanical dead space
- Position patient appropriately to optimize ventilation-perfusion matching
- Consider prone positioning in severe ARDS
Managing Patient-Ventilator Synchrony
1. Auto-triggering:
- Increase trigger sensitivity threshold
- Check for circuit leaks
- Manage cardiac oscillations
2. Ineffective triggering:
- Decrease trigger sensitivity threshold
- Address auto-PEEP: increase expiratory time, decrease minute ventilation
- Consider adding external PEEP in COPD patients
3. Double-triggering:
- Increase inspiratory time
- Adjust inspiratory flow rate
- Consider switching to pressure support for spontaneously breathing patients
4. Flow asynchrony:
- Adjust rise time settings
- Modify inspiratory time
- Consider pressure support mode if patient is triggering breaths
5. Cycle asynchrony:
- Adjust expiratory trigger sensitivity (if available)
- Modify inspiratory time settings
Special Considerations by Patient Population
ARDS Management
1. Lung-protective ventilation strategy:
- Target tidal volumes 4-8 mL/kg predicted body weight
- Keep plateau pressure <30 cmH₂O
- Maintain driving pressure <15 cmH₂O
- Use appropriate PEEP to maintain alveolar recruitment
2. Prone positioning:
- Consider for P/F ratio <150 mmHg despite optimized ventilation
- Implement for 12-16 hours per session
- Monitor for complications including pressure ulcers, endotracheal tube displacement
3. Adjunctive therapies:
- Neuromuscular blockade for severe ARDS in first 48 hours
- Consider inhaled pulmonary vasodilators for refractory hypoxemia
- Evaluate for ECMO referral if severe, refractory hypoxemia persists
Obstructive Lung Disease (Asthma, COPD)
1. Ventilator strategy:
- Prioritize longer expiratory times (I:E ratio ≥1:3)
- Accept higher PaCO₂ (permissive hypercapnia) if pH >7.20
- Monitor and manage auto-PEEP
- Consider external PEEP at 80% of measured auto-PEEP
2. Bronchodilator therapy:
- Optimize delivery via in-line nebulizers or metered-dose inhalers
- Consider continuous nebulization for severe bronchospasm
Neurocritical Care
1. Ventilator strategy:
- Target normocapnia (PaCO₂ 35-40 mmHg) unless specific indications for hyper- or hypoventilation
- Maintain adequate oxygenation (PaO₂ >80 mmHg)
- Consider effect of PEEP on intracranial pressure
2. Monitoring considerations:
- Intracranial pressure monitoring
- Cerebral perfusion pressure
- Brain tissue oxygenation
Post-Cardiac Surgery
1. Ventilator strategy:
- Consider moderate PEEP (8-10 cmH₂O) to prevent atelectasis
- Monitor hemodynamic response to positive pressure
- Early transition to pressure support when feasible
2. Monitoring considerations:
- Cardiac output/index
- Mixed venous oxygen saturation
- Lactate trends
Troubleshooting Common Issues in PCV
Hypoxemia
1. Assessment:
- Verify ETT position and patency
- Evaluate for disconnection, circuit leak
- Assess for pneumothorax, atelectasis, secretions
- Rule out endobronchial intubation
2. Interventions:
- Increase FiO₂
- Optimize PEEP
- Consider recruitment maneuver
- Evaluate need for bronchoscopy
- Consider prone positioning
- Rule out and treat underlying cause
Hypercapnia
1. Assessment:
- Evaluate for hypoventilation
- Check for increased dead space ventilation
- Assess for increased CO₂ production (fever, overfeeding, seizures)
- Verify ventilator function
2. Interventions:
- Increase respiratory rate
- Increase driving pressure (monitor plateau pressure)
- Optimize I:E ratio
- Consider permissive hypercapnia if clinically appropriate
- Address underlying causes
Auto-PEEP
1. Assessment:
- Perform end-expiratory hold maneuver to measure
- Evaluate flow-time curve for incomplete exhalation
- Risk factors: high minute ventilation, short expiratory time, airflow obstruction
2. Interventions:
- Decrease respiratory rate
- Decrease inspiratory time (shorten I:E ratio)
- Optimize bronchodilator therapy
- Consider external PEEP (typically 70-80% of measured auto-PEEP)
Barotrauma
1. Assessment:
- Monitor for pneumothorax, pneumomediastinum, subcutaneous emphysema
- Risk factors: high plateau pressures, high PEEP, underlying lung disease
2. Interventions:
- Reduce driving pressure
- Optimize PEEP
- Consider permissive hypercapnia
- Chest tube placement for pneumothorax
Hemodynamic Compromise
1. Assessment:
- Evaluate preload: CVP, stroke volume variation
- Assess cardiac function: cardiac output/index, echocardiography
- Consider vasopressor requirement
2. Interventions:
- Volume resuscitation if hypovolemic
- Reduce mean airway pressure if tolerated
- Decrease PEEP incrementally
- Inotropic support if indicated
- Vasopressor therapy if indicated
Evidence-Based Approaches to Ventilator Liberation and Weaning
Readiness Assessment
1. Clinical criteria:
- Resolution or improvement in underlying cause of respiratory failure
- Adequate oxygenation: PaO₂/FiO₂ >200 mmHg with PEEP ≤8 cmH₂O and FiO₂ ≤0.5
- Hemodynamic stability: no vasopressors or low-dose vasopressors
- Ability to initiate spontaneous breathing effort
- Adequate mental status
2. Weaning predictors:
- Rapid shallow breathing index (RSBI) <105 breaths/min/L
- Maximum inspiratory pressure <-20 to -25 cmH₂O
- Vital capacity >10-15 mL/kg
- Minute ventilation <10 L/min
Weaning Strategies
1. Gradual transition to assisted modes:
- PC-CSV (pressure-controlled synchronized ventilation)
- Pressure support ventilation (PSV)
- Proportional assist ventilation (PAV)
- Neurally adjusted ventilatory assist (NAVA)
2. Progressive parameter reduction:
- Gradual reduction in driving pressure
- Decrease in respiratory rate
- Reduction in PEEP and FiO₂
3. Spontaneous breathing trials (SBT):
- T-piece trial: ETT connected to oxygen source without ventilator support
- PSV trial: Low level pressure support (5-8 cmH₂O) with minimal PEEP
- CPAP trial: CPAP 5 cmH₂O without pressure support
- Duration: 30-120 minutes
4. Post-extubation support:
- High-flow nasal cannula
- Non-invasive ventilation for high-risk patients
- Conventional oxygen therapy
Difficult Weaning Management
1. Identify causes:
- Respiratory muscle weakness
- Increased work of breathing
- Cardiac dysfunction
- Neurological impairment
- Psychological factors
2. Targeted interventions:
- Respiratory muscle training
- Optimize nutrition
- Treat heart failure if present
- Address psychological factors
- Consider tracheostomy for prolonged weaning
3. Alternative approaches:
- Progressive weaning trials
- Automated weaning systems
- Consider specialized weaning units
Prevention and Management of Complications
Ventilator-Induced Lung Injury (VILI)
1. Prevention strategies:
- Lung-protective ventilation
- Appropriate PEEP selection
- Minimize driving pressure
- Avoid excessive tidal volumes
- Prone positioning when indicated
2. Monitoring for VILI:
- Deteriorating oxygenation
- Worsening compliance
- New infiltrates on chest imaging
- Inflammatory biomarkers (if available)
Ventilator-Associated Pneumonia (VAP)
1. Prevention bundle:
- Head of bed elevation 30-45°
- Daily sedation interruption and assessment for extubation
- Oral care with chlorhexidine
- Subglottic secretion drainage
- Maintain endotracheal cuff pressure 20-30 cmH₂O
2. Surveillance and diagnosis:
- Clinical Pulmonary Infection Score (CPIS)
- Quantitative cultures of lower respiratory tract specimens
- Biomarkers: procalcitonin, C-reactive protein
3. Management:
- Empiric antimicrobial therapy based on local antibiogram
- De-escalation based on culture results
- Short course therapy (7-8 days) for responders
ICU-Acquired Weakness
1. Prevention strategies*l:
- Early mobilization
- Minimize sedation
- Glycemic control
- Minimize use of neuromuscular blocking agents
2. Assessment:
- Medical Research Council (MRC) sum score
- Hand grip strength
- Physical Function in ICU Test (PFIT)
3. Management:
- Progressive mobility program
- Physical therapy
- Occupational therapy
- Nutritional optimization
Diaphragmatic Dysfunction
1. Prevention strategies:
- Avoid excessive sedation
- Maintain appropriate ventilatory support
- Minimize duration of controlled ventilation
- Early implementation of assisted modes
2. Assessment:
- Ultrasound measurement of diaphragm thickness and excursion
- Electrical activity of the diaphragm (if NAVA available)
- Transdiaphragmatic pressure measurement
3. Management:
- Inspiratory muscle training
- Optimize nutrition
- Appropriate weaning strategy
Integration of Advanced Monitoring Techniques
Esophageal Pressure Monitoring
1. Indications:
- Difficult-to-manage ARDS
- Morbid obesity
- Suspected high pleural pressures
- Difficult PEEP titration
2. Parameters derived:
- Transpulmonary pressure
- Chest wall compliance
- Respiratory muscle effort
3. Clinical applications:
- PEEP titration based on end-expiratory transpulmonary pressure
- Assessment of driving transpulmonary pressure
- Work of breathing evaluation
Electrical Impedance Tomography (EIT)
1. Principles:
- Real-time imaging of ventilation distribution
- Non-invasive monitoring at bedside
2. Clinical applications:
- PEEP optimization
- Positioning optimization
- Detection of pneumothorax
- Assessment of recruitment maneuvers
Advanced Hemodynamic Monitoring
1. Pulse contour analysis:
- Continuous cardiac output monitoring
- Stroke volume variation
- Pulse pressure variation
2. Echocardiography:
- Assessment of cardiac function
- Evaluation of preload responsiveness
- Monitoring for right ventricular dysfunction
3. Integration with respiratory monitoring:
- Heart-lung interactions
- Assessment of preload responsiveness
- Evaluation of ventricular interdependence
Future Directions in PCV Management
Automated Systems
1. Closed-loop ventilation:
- Automated FiO₂ adjustment
- Automated pressure/PEEP adjustment
- Smart targeting of ventilation
2. Computer-assisted management:
- Decision support systems
- Predictive analytics for weaning
- Early warning systems for complications
Personalized Ventilation Strategies
1. Biological phenotyping:
- Inflammatory vs. non-inflammatory ARDS
- Airway-predominant vs. parenchymal pathology
2. Mechanical phenotyping:
- Recruitability assessment
- Stress index evaluation
- Elastance-based PEEP titration
Integration with Extracorporeal Support
1. Extracorporeal CO₂ removal (ECCO₂R):
- Ultra-protective ventilation strategies
- Facilitation of weaning in difficult cases
2. Extracorporeal membrane oxygenation (ECMO):
- Very severe ARDS management
- "Lung rest" ventilation strategies
Conclusion
The management of patients on pressure-controlled ventilation requires a systematic approach integrating clinical assessment, continuous monitoring, and evidence-based interventions. By focusing on physiologic principles, individualized assessment, and targeted interventions, clinicians can optimize outcomes while minimizing complications. Regular reassessment and adjustment of the ventilation strategy based on the patient's evolving condition is essential for successful management.
The field continues to evolve with advances in monitoring technologies, automated systems, and personalized approaches to mechanical ventilation. Integrating these advances into clinical practice while maintaining focus on fundamental principles of respiratory physiology will further improve outcomes for critically ill patients requiring mechanical ventilation.
References
Amato MB, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372(8):747-755.
ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526-2533.
Barbas CS, Ísola AM, Farias AM, et al. Brazilian recommendations of mechanical ventilation 2013. Part I. Rev Bras Ter Intensiva. 2014;26(2):89-121.
Beitler JR, Sarge T, Banner-Goodspeed VM, et al. Effect of titrating positive end-expiratory pressure (PEEP) with an esophageal pressure-guided strategy vs an empirical high PEEP-FiO₂ strategy on death and days free from mechanical ventilation among patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA. 2019;321(9):846-857.
Blanch L, Villagra A, Sales B, et al. Asynchronies during mechanical ventilation are associated with mortality. Intensive Care Med. 2015;41(4):633-641.
Briel M, Meade M, Mercat A, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA. 2010;303(9):865-873.
Brochard L, Slutsky A, Pesenti A. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med. 2017;195(4):438-442.
Chatburn RL, El-Khatib M, Mireles-Cabodevila E. A taxonomy for mechanical ventilation: 10 fundamental maxims. Respir Care. 2014;59(11):1747-1763.
Chiumello D, Carlesso E, Brioni M, Cressoni M. Airway driving pressure and lung stress in ARDS patients. Crit Care. 2016;20:276.
Constantin JM, Jabaudon M, Lefrant JY, et al. Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single-blind, randomised controlled trial. Lancet Respir Med. 2019;7(10):870-880.
Donaldson S, Wijewardena A, Kavanagh BP. Pressure controlled vs. volume controlled ventilation: does it matter? Curr Opin Crit Care. 2020;26(1):76-82.
Gattinoni L, Carlesso E, Cadringher P, et al. Physical and biological triggers of ventilator-induced lung injury and its prevention. Eur Respir J. 2003;22(Suppl 47):15s-25s.
Girard TD, Alhazzani W, Kress JP, et al. An Official American Thoracic Society/American College of Chest Physicians Clinical Practice Guideline: Liberation from Mechanical Ventilation in Critically Ill Adults. Am J Respir Crit Care Med. 2017;195(1):120-133.
Goligher EC, Dres M, Fan E, et al. Mechanical Ventilation-induced Diaphragm Atrophy Strongly Impacts Clinical Outcomes. Am J Respir Crit Care Med. 2018;197(2):204-213.
Guérin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159-2168.
Hess DR. Recruitment maneuvers and PEEP titration. Respir Care. 2015;60(11):1688-1704.
Jamil Q, Al-Ani A, Al-Nuaimi H. Pressure vs volume control modes for ventilated patients with acute respiratory failure: A systematic review and meta-analysis of randomized controlled trials. Int J Crit Illn Inj Sci. 2023;13(1):7-14.
Kallet RH, Matthay MA. Hyperoxic acute lung injury. Respir Care. 2013;58(1):123-141.
Kluge S, Janssens U, Welte T, et al. German recommendations for critically ill patients with COVID‑19. Med Klin Intensivmed Notfmed. 2020;115(Suppl 3):111-114.
Laffey JG, Bellani G, Pham T, et al. Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study. Intensive Care Med. 2016;42(12):1865-1876.
Marini JJ, Gattinoni L. Ventilatory management of acute respiratory distress syndrome: a consensus of two. Crit Care Med. 2004;32(1):250-255.
Mehta S, Burns KEA, Machado FR, et al. Gender parity in critical care medicine. Am J Respir Crit Care Med. 2017;196(4):425-429.
Modrykamien A
&&&&&&&&&&&&••••&&&&&&&&•
Modrykamien A, Chatburn RL. What is the optimal ventilator strategy in acute respiratory distress syndrome? Respir Care. 2013;58(2):371-387.
Munshi L, Del Sorbo L, Adhikari NKJ, et al. Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc. 2017;14(Supplement_4):S280-S288.
Neto AS, Hemmes SN, Barbas CS, et al. Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data. Lancet Respir Med. 2016;4(4):272-280.
Nguyen HB, Rivers EP, Abrahamian FM, et al. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med. 2006;48(1):28-54.
Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107-1116.
Pham T, Rubenfeld GD. Fifty Years of Research in ARDS. The Epidemiology of Acute Respiratory Distress Syndrome. A 50th Birthday Review. Am J Respir Crit Care Med. 2017;195(7):860-870.
Piraino T, Cook DJ, Brochard L. Electrical impedance tomography in the clinical assessment of lung volumes following recruitment manoeuvres. Crit Care. 2021;25(1):152.
Rittayamai N, Katsios CM, Beloncle F, et al. Pressure-controlled vs volume-controlled ventilation in acute respiratory failure: A physiology-based narrative and systematic review. Chest. 2015;148(2):340-355.
Schmidt GA, Girard TD, Kress JP, et al. Official Executive Summary of an American Thoracic Society/American College of Chest Physicians Clinical Practice Guideline: Liberation from Mechanical Ventilation in Critically Ill Adults. Am J Respir Crit Care Med. 2017;195(1):115-119.
Schreiber JU, Lysakowski C, Fuchs-Buder T, Tramèr MR. Prevention of succinylcholine-induced fasciculation and myalgia: a meta-analysis of randomized trials. Anesthesiology. 2005;103(4):877-884.
Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369(22):2126-2136.
Spieth PM, Koch T, Gama de Abreu M. Approaches to ventilation in intensive care. Dtsch Arztebl Int. 2014;111(42):714-720.
Suarez-Sipmann F, Böhm SH, Tusman G, et al. Use of dynamic compliance for open lung positive end-expiratory pressure titration in an experimental study. Crit Care Med. 2007;35(1):214-221.
The National Heart, Lung, and Blood Institute PETAL Clinical Trials Network. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. N Engl J Med. 2019;380(21):1997-2008.
Tobin MJ. Principles and Practice of Mechanical Ventilation. 3rd ed. McGraw-Hill Education / Medical; 2012.
Umbrello M, Formenti P, Longhi D, et al. Diaphragm ultrasound as indicator of respiratory effort in critically ill patients undergoing assisted mechanical ventilation: a pilot clinical study. Crit Care. 2015;19:161.
Vaporidi K, Akoumianaki E, Telias I, et al. Respiratory drive in critically ill patients: pathophysiology and clinical implications. Am J Respir Crit Care Med. 2020;201(1):20-32.
Vasques F, Duscio E, Cipulli F, et al. Is the mechanical power the final word on ventilator-induced lung injury?-we are not sure. Ann Transl Med. 2018;6(19):395.
Villar J, Ferrando C, Martínez D, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267-276.
Vincent JL, Creteur J. The hospital of tomorrow in 10 points. Crit Care. 2017;21(1):93.
Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART) Investigators. Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA. 2017;318(14):1335-1345.
Yoshida T, Fujino Y, Amato MB, Kavanagh BP. Fifty Years of Research in ARDS. Spontaneous Breathing during Mechanical Ventilation. Risks, Mechanisms, and Management. Am J Respir Crit Care Med. 2017;195(8):985-992.
Zampieri FG, Azevedo LCP, Corrêa TD, et al. Study protocol for the Balanced Solution versus Saline in Intensive Care Study (BaSICS): a factorial randomised trial. Crit Care Resusc. 2017;19(2):175-182.
Zhao Z, Möller K, Steinmann D, Frerichs I, Guttmann J. Evaluation of an electrical impedance tomography-based global inhomogeneity index for pulmonary ventilation distribution. Intensive Care Med. 2009;35(11):1900-1906.
Practice Points
1. Initial PCV setup
- Target tidal volumes of 6-8 mL/kg predicted body weight
- Start with moderate PEEP (5-8 cmH₂O) and titrate based on oxygenation
- Set respiratory rate to achieve normal pH, accepting permissive hypercapnia when appropriate
- Adjust inspiratory time to achieve appropriate I:E ratio (typically 1:2)
2. Monitoring priorities
- Track delivered tidal volumes despite using a pressure-controlled mode
- Monitor plateau pressure (should remain <30 cmH₂O)
- Calculate and monitor driving pressure (plateau pressure - PEEP)
- Evaluate for patient-ventilator asynchrony regularly
3. Oxygenation management
- Use PEEP/FiO₂ tables or titration strategies to optimize PEEP
- Target SpO₂ 92-96% (88-92% in COPD)
- Consider prone positioning for P/F ratio <150 mmHg
- Reserve inverse ratio ventilation for refractory hypoxemia
4. Ventilation management
- Accept permissive hypercapnia (pH >7.25) when appropriate
- Adjust respiratory rate before driving pressure to manage PaCO₂
- Monitor and manage auto-PEEP, especially in obstructive lung disease
- Consider dead space optimization strategies
5. Prevention of complications
- Implement VAP prevention bundle
- Early mobilization to prevent ICU-acquired weakness
- Daily assessment of readiness for liberation from mechanical ventilation
- Minimize sedation and use daily interruption protocols
Research Directions
Future research in pressure-controlled ventilation should focus on several key areas:
1. Personalized ventilation strategies
- Development of predictive models for optimal PCV parameters based on patient characteristics
- Further refinement of biological and mechanical phenotyping approaches in ARDS
- Validation of point-of-care tests to guide ventilator management
2. Advanced monitoring implementation
- Clinical validation of electrical impedance tomography for routine clinical use
- Development of simplified esophageal pressure monitoring techniques
- Integration of multiple monitoring modalities into decision support systems
3. Automated ventilator management
- Refinement of closed-loop systems for FiO₂, PEEP, and pressure control adjustments
- Validation of computer-assisted management protocols
- Development of artificial intelligence algorithms for ventilator management
4. Novel weaning strategies
- Comparison of various assisted modes for ventilator liberation
- Development of predictive algorithms for weaning success
- Optimization of post-extubation support strategies
5. Long-term outcomes
- Impact of various ventilation strategies on long-term pulmonary function
- Prevention of post-intensive care syndrome
- Cost-effectiveness analyses of advanced ventilation management strategies
As our understanding of the pathophysiology of respiratory failure and the mechanisms of ventilator-induced lung injury continues to evolve, so too will our approach to mechanical ventilation. The integration of advanced monitoring techniques, automated systems, and personalized approaches holds promise for further improving outcomes in critically ill patients requiring pressure-controlled ventilation.
No comments:
Post a Comment